|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.7 USD | +0.77% |
|
+4.47% | +20.53% |
| 05:51pm | Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141 | MT |
| 05:05pm | Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128 | MT |
--Merck & Co.'s Japan unit applied for approval of its Covid-19 pill in the country, local business daily Nikkei reported Friday, citing unnamed sources.
--If approved by the government, Merck plans to distribute the pill in Japan as early as later this month, the Nikkei report said.
Full story: https://s.nikkei.com/3DjwETO (Japanese)
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
12-03-21 0201ET
| 1st Jan change | Capi. | |
|---|---|---|
| +20.53% | 331B | |
| +26.21% | 653B | |
| +27.00% | 556B | |
| -6.72% | 354B | |
| +2.07% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.24% | 144B | |
| -11.57% | 143B |
MERCK & CO., INC. 
